Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

BACKGROUND: Inhaled nitric oxide (iNO) has been widely used in patients with COVID-19-related acute respiratory distress syndrome (C-ARDS), though its physiological effects and outcome are debated in this setting. The objective of this cohort study was to describe the modalities of iNO use, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekontso Dessap, Armand, Papazian, Laurent, Schaller, Manuella, Nseir, Saad, Megarbane, Bruno, Haudebourg, Luc, Timsit, Jean-François, Teboul, Jean-Louis, Kuteifan, Khaldoun, Gainnier, Marc, Slama, Michel, Houeto, Patrick, Lecourt, Laurent, Mercat, Alain, Vieillard-Baron, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299982/
https://www.ncbi.nlm.nih.gov/pubmed/37368036
http://dx.doi.org/10.1186/s13613-023-01150-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299982/
https://www.ncbi.nlm.nih.gov/pubmed/37368036
http://dx.doi.org/10.1186/s13613-023-01150-9

Ejemplares similares